These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18419109)

  • 41. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling.
    Delogu GL; Matos MJ; Fanti M; Era B; Medda R; Pieroni E; Fais A; Kumar A; Pintus F
    Bioorg Med Chem Lett; 2016 May; 26(9):2308-13. PubMed ID: 26995529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Search for dual function inhibitors for Alzheimer's disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Abeta fibril formation inhibition capacity.
    Kapková P; Alptüzün V; Frey P; Erciyas E; Holzgrabe U
    Bioorg Med Chem; 2006 Jan; 14(2):472-8. PubMed ID: 16198581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL; Sun YX; Jiang ZF
    FEBS Lett; 2007 Apr; 581(7):1269-74. PubMed ID: 17349630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
    Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
    Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains.
    Ono M; Kawashima H; Nonaka A; Kawai T; Haratake M; Mori H; Kung MP; Kung HF; Saji H; Nakayama M
    J Med Chem; 2006 May; 49(9):2725-30. PubMed ID: 16640332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.
    Shi A; Huang L; Lu C; He F; Li X
    Bioorg Med Chem; 2011 Apr; 19(7):2298-305. PubMed ID: 21397508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
    Fernández-Bachiller MI; Pérez C; González-Muñoz GC; Conde S; López MG; Villarroya M; García AG; Rodríguez-Franco MI
    J Med Chem; 2010 Jul; 53(13):4927-37. PubMed ID: 20545360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
    Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
    Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Syntheses of tetrahydrofurobenzofurans and dihydromethanobenzodioxepines from 5-hydroxy-3-methyl-3H-benzofuran-2-one. Rearrangement and ring expansion under reductive conditions on treatment with hydrides.
    Luo W; Yu QS; Holloway HW; Parrish D; Greig NH; Brossi A
    J Org Chem; 2005 Aug; 70(16):6171-6. PubMed ID: 16050674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
    Rouleau J; Iorga BI; Guillou C
    Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation.
    Karlsson D; Fallarero A; Brunhofer G; Guzik P; Prinz M; Holzgrabe U; Erker T; Vuorela P
    Eur J Pharm Sci; 2012 Jan; 45(1-2):169-83. PubMed ID: 22108346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
    Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B
    Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by beta-amyloid (1-42).
    Lee KH; Shin BH; Shin KJ; Kim DJ; Yu J
    Biochem Biophys Res Commun; 2005 Mar; 328(4):816-23. PubMed ID: 15707952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of dendrimer's structure on its activity against amyloid fibril formation.
    Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
    Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin.
    Giunta S; Galeazzi R; Marcellini M; Corder EH; Galeazzi L
    Clin Biochem; 2007 Aug; 40(12):887-92. PubMed ID: 17512513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and biological activity of beta-sheet breaker peptide conjugates.
    Rocha S; Cardoso I; Börner H; Pereira MC; Saraiva MJ; Coelho M
    Biochem Biophys Res Commun; 2009 Mar; 380(2):397-401. PubMed ID: 19250644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and cholinesterase inhibitory activity of new 2-benzofuran carboxamide-benzylpyridinum salts.
    Abedinifar F; Farnia SMF; Mahdavi M; Nadri H; Moradi A; Ghasemi JB; Küçükkılınç TT; Firoozpour L; Foroumadi A
    Bioorg Chem; 2018 Oct; 80():180-188. PubMed ID: 29929079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
    Rosini M; Simoni E; Bartolini M; Tarozzi A; Matera R; Milelli A; Hrelia P; Andrisano V; Bolognesi ML; Melchiorre C
    Eur J Med Chem; 2011 Nov; 46(11):5435-42. PubMed ID: 21924801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment.
    Montanari S; Mahmoud AM; Pruccoli L; Rabbito A; Naldi M; Petralla S; Moraleda I; Bartolini M; Monti B; Iriepa I; Belluti F; Gobbi S; Di Marzo V; Bisi A; Tarozzi A; Ligresti A; Rampa A
    Eur J Med Chem; 2019 Sep; 178():243-258. PubMed ID: 31185414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer´s disease therapy.
    Hiremathad A; Chand K; Tolayan L; Rajeshwari ; Keri RS; Esteves AR; Cardoso SM; Chaves S; Santos MA
    J Inorg Biochem; 2018 Feb; 179():82-96. PubMed ID: 29182921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.